Target intelligence / Profile preview

Long intergenic non-protein coding RNA 703 (LINC00703)

Target
LINC00703
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 703 (LINC00703) is a long non-coding RNA gene located on chromosome 10 (10p15.1), classified as an lncRNA without protein-coding capacity[1][5][11][13]. It functions as a tumor suppressor in several cancers, particularly gastric cancer and non-small cell lung cancer, through its ability to regulate gene expression post-transcriptionally. LINC00703 acts as a competing endogenous RNA (ceRNA) for miR-181a, thereby increasing the expression of the tumor suppressor KLF6, inhibiting cell proliferation, migration, invasion, and promoting apoptosis[2][4]. Its downregulation is associated with tumorigenesis, while overexpression suppresses tumor cell growth, indicating potential utility as both a diagnostic/prognostic biomarker and a therapeutic target in oncology. No drugs targeting LINC00703 are currently reported in humans, but its roles as a ceRNA and regulator of key cell cycle and apoptosis genes make it a subject of ongoing research[2][4][13].

Other names
LINC00703
02

Mechanism of action

Modulates expression of specific mRNAs by acting as a molecular sponge for microRNAs (e.g., sequestering miR-181a, leading to derepression/upregulation of KLF6 tumor suppressor gene)[2][4]; Alters cell cycle regulators (e.g., downregulates cyclin D1 and CDK4 in non-small cell lung cancer)[4]

03

Biological functions

Regulation of gene expression (acts as a competing endogenous RNA or "miRNA sponge")Regulation of cell proliferationPromotion of apoptosisInhibition of cell migration and invasionCell cycle regulation
04

Disease associations

Cancer (notably gastric cancer and non-small cell lung cancer)Tumor suppressor role
05

Safety considerations

No specific safety concerns or therapeutic challenges are reported; as with other lncRNAs, challenges may include targeted delivery, specificity, and potential off-target effects (inferred)
06

Biomarkers

Reduced expression can serve as a biomarker for diagnosis or prognosis in gastric cancer and non-small cell lung cancer[2][4][6]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 703 (LINC00703).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 703 (LINC00703).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call